Finance

Beta
Lists
MRKR:NASDAQ
Marker Therapeutics Inc
$1.57
+3.97%
(+0.060) 1D
$1.59
+1.27% (+0.020)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRKR...
Open
$1.46
High
$1.59
Low
$1.46
Mkt. cap
26.18M
Avg. vol.
70.14K
Volume
92.28K
52-wk high
$4.07
52-wk low
$0.81
EPS
-$0.66
Beta
1.43
Shares outstanding
16.67M
No. of employees
5
Open
$1.46
High
$1.59
Low
$1.46
Mkt. cap
26.18M
Avg. vol.
70.14K
Volume
92.28K
52-wk high
$4.07
52-wk low
$0.81
EPS
-$0.66
Beta
1.43
Shares outstanding
16.67M
No. of employees
5
News stories
From sources across the web
About Marker Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitemarkertherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
861.18K
1.23M
1.10M
751.69K
Cost of goods sold
4.18M
2.35M
2.14M
2.84M
Cost of revenue
4.18M
2.35M
2.14M
2.84M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
945.16K
1.02M
846.61K
1.23M
Operating expense
945.16K
1.02M
846.61K
1.23M
Total operating expenses
5.12M
3.37M
2.99M
4.07M
Operating income
-4.26M
-2.14M
-1.88M
-4.07M
Other non operating income
117.44K
-
-
760.37K
EBT including unusual items
-4.02M
-2.00M
-1.72M
-3.18M
EBT excluding unusual items
-4.02M
-2.00M
-1.72M
-3.18M
Income tax expense
-
-
-15.16K
-
Effective tax rate
-
-
0.88%
-
Other operating expenses
-
-
-
-
Net income
-4.02M
-2.00M
-1.70M
-3.18M
Net profit margin
-466.28%
-162.11%
-154.35%
-
Earnings per share
-0.29
-0.12
-0.04
-0.16
Interest and investment income
128.02K
138.06K
165.63K
132.89K
Interest expense
-
-
-
-
Net interest expenses
128.02K
138.06K
165.63K
132.89K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer